Therapath LLC was awarded a $630,720 firm fixed price purchase order by the Department of the Army Medical Command to perform nerve fiber testing services for Madigan Army Medical Center in Tacoma, Washington. The original pre-solicitation notice sought market research to determine small business interest in conducting epidermal nerve fiber density testing of the upper and lower extremities, as well as sweat gland analysis. Testing services are to be performed at Therapath's laboratory in New...
Therapath Partners LLC, a subsidiary of Inform Diagnostics, Inc., has been awarded a delivery order against an indefinite-delivery contract to provide neuropathology testing and supplies in support of the New Jersey VA Healthcare System. The $1,454.05 firm fixed price order was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 on March 15, 2022 for testing services to be completed by March 14, 2027. Therapath Partners holds two...
This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Therapath Partners LLC, a subsidiary of Inform Diagnostics, Inc. The contract is for $231,848.13 to provide neuropathology testing services to support the VA's healthcare facilities. It is not set aside for any specific business category. The contract is part of a larger Indefinite Delivery Contract (IDC) awarded by the VA's Veterans Integrated Service Network (VISN) 8, which has a ceiling value of...
<p>This is a firm fixed-price delivery order contract awarded by the Department of the Army Medical Command to Therapath LLC, a for-profit limited liability company, to provide nerve fiber testing services at Madigan Army Medical Center in Tacoma, Washington. The contract has a potential value of $210,240.00 and a completion date of September 30, 2018. The contract is not associated with a set-aside designation.</p>
This is a $256,200.00 firm-fixed-price purchase order awarded to Inform Diagnostics, Inc. by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 10 (VISN 10). The contract is for the provision of muscle and nerve testing services at the John D. Dingell VA Medical Center in Detroit, Michigan. The contract has a base year with four additional option years, extending through April 30, 2030. The contract was awarded without a set-aside designation, as the services provided by...
This is a Firm Fixed Price Delivery Order contract awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 to Therapath LLC, a for-profit limited liability company, to provide neuropathology testing and supply services. The contract has a potential value of $449,109.56 and a completion date of September 30, 2021. No set-aside designation is specified. The contract is for the delivery of neuropathology testing and related supplies to...
This delivery order against an unspecified government-wide acquisition contract (GWAC) awards Therapath Partners LLC $119,751.10 to provide neuropathology testing and supply services to the New Jersey VA Healthcare System. As a subcontractor to its parent company Inform Diagnostics, Inc., Therapath will support the Veterans Health Administration's Veterans Integrated Service Network 2 by fulfilling the clinical laboratory needs of the East Orange, New Jersey medical center. No set-aside...
This federal contract award was issued by the Defense Health Agency (DHA) to Cytopath Biopsy Lab Inc. (doing business as Cblpath), a provider of specialized anatomic pathology and molecular diagnostic laboratory services. The $105,000.00 firm fixed price purchase order is for "THYRO SEQUENCE TESTING" services to support cancer screening and diagnosis programs within the defense health system. Cytopath Biopsy Lab Inc. has previously provided similar ThyroSeq molecular diagnostic testing...
This is a firm fixed price purchase order for $77,440.80 awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Cytopath Biopsy Lab Inc. (doing business as Cblpath) to provide laboratory testing services related to the ThyroSeq V.2 molecular diagnostic test. The award supports the agency's cancer screening and diagnosis programs, particularly for veterans and active military members. Cytopath Biopsy Lab Inc. has provided similar ThyroSeq testing services to...
This federal contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, is for the provision of TYROSEQ V.2 MOLECULAR TESTING services. The $150,000.00 firm fixed price purchase order was issued by the Defense Health Agency and does not have a set-aside designation. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with a focus on cancer screening and diagnosis utilizing next generation genomic sequencing under...